MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome

被引:7
|
作者
Men, Yu [1 ]
Zhai, Yirui [2 ]
Wu, Lihong [3 ]
Liu, Lipin [4 ]
Zhang, Wenjue [2 ,5 ]
Jiang, Wei [2 ,5 ]
Bi, Nan [2 ]
Song, Yongmei [6 ]
Hui, Zhouguang [1 ]
Wang, Luhua [2 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept VIP Med Serv & Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Genecast Precis Med Technol Inst, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Beijing Hosp, Natl Ctr Gerontol, Inst Geriatr Med,Dept Radiat Oncol, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Beijing, Guangdong, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; miR-323a-3p; FMR1; RHEUMATOID-ARTHRITIS; EXPRESSION; MICRORNA-323-3P; IDENTIFICATION; METASTASIS; BIOMARKER; CANCER; PROGRESSION; INVASION; IMPACT;
D O I
10.1186/s12935-022-02541-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Esophageal squamous cell carcinoma (ESCC) has unfavorable outcomes with the highest incidence seen in China. Accordingly, exploring effective molecular biomarkers is of great value. MicroRNAs (miRNAs) are posttranscriptional regulators of gene expression and modulate numerous biological processes in tumors. Our study aimed to identify prognostic miRNAs and investigate their role in ESCC. Methods Prognosis-related plasma miRNAs were detected by miRNA microarray and qRT-PCR. Functional assays and molecular mechanism studies were used to investigate the role of miRNA in ESCC. Results Over-expression of miR-323a-3p was associated with a favorable prognosis. MiR-323a-3p negatively regulated proliferation, migration, and invasion. Through biological predictions, the fragile X mental retardation 1 (FMR1) was found to be a potential target of miR-323a-3p. Further investigation revealed that miR-323a-3p directly targeted and suppressed FMR1. MiR-323a-3p and FMR1 mRNA, as well as miR-323a-3p and the FMR1-encoded protein FMRP, showed negative correlations. Luciferase activity of FMR1-3 '-UTR, but not mutant counterparts, was decreased by mimic compared with that of the control. The compromised cell proliferation, migration, and invasion induced by transfection with miR-323a-3p mimic were rescued by transfection with a FMR1 expression plasmid. Tumors induced by miR-323a-3p overexpressed ESCC cells grew significantly slower in vivo and resulted in smaller tumor masses. Metastatic lung colonization was also inhibited by miR-323a-3p overexpression. Conclusions MiR-323a-3p was significantly associated with survival and acted as a tumor suppressor by inhibiting proliferation, migration, and invasion via the regulation of FMR1. MiR-323a-3p is a promising biomarker and may be a potential therapeutic target.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p
    Dongbo Luo
    Adili Salai
    Hongbo Lv
    Yang Wang
    Yunfei Gao
    Clinical and Translational Oncology, 2022, 24 : 1954 - 1963
  • [22] Characterization of a novel tumor-suppressor gene PLCδ1 at 3p22 in Esophageal squamous cell carcinoma
    Fu, Li
    Qin, Yan-Ru
    Xie, Dan
    Flu, Liang
    Kwong, Dora L.
    Srivastava, Gopesh
    Tsao, Sai Wah
    Guan, Xin-Yuan
    CANCER RESEARCH, 2007, 67 (22) : 10720 - 10726
  • [23] miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting FGFR2/FRS2
    Shan, Xia
    Zhang, Cheng
    Li, Chunyu
    Fan, Xingchen
    Song, Guoxin
    Zhu, Jingfeng
    Cao, Risheng
    Zhang, Xiuwei
    Zhu, Wei
    CANCER PATHOGENESIS AND THERAPY, 2023, 1 (02): : 87 - 97
  • [24] Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma
    Pan, Hao
    Gu, Liqun
    Liu, Binjie
    Li, Yiping
    Wang, Yuehong
    Bai, Xinna
    Li, Long
    Wang, Baisheng
    Peng, Qian
    Yao, Zhigang
    Tang, Zhangui
    PLOS ONE, 2017, 12 (02):
  • [25] Characterization of a novel tumor-suppressor gene CHL1 at 3p26.3 in esophageal squamous cell carcinoma
    Wang, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] LncRNA MIR100HG acts as a Tumor Promoter in Esophageal Squamous Cell Carcinoma Regulating miR-488-3p/FZD4 Axis
    Xuan, Jingjing
    Shan, Caiyun
    Ren, Xiangfeng
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 12 - 12
  • [27] Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients
    Hoshino, Isamu
    Matsubara, Hisahiro
    Akutsu, Yasunori
    Nishimori, Takanori
    Yoneyama, Yasuo
    Murakami, Kentaro
    Sakata, Haruhito
    Matsushita, Kazuyuki
    Ochiai, Takenori
    ONCOLOGY REPORTS, 2007, 18 (04) : 867 - 871
  • [28] Characterization of a candidate tumor suppressor gene DIRAS1 in esophageal squamous cell carcinoma
    Zhu, Yinghui
    Chen, Polly Leilei
    Fu, Li
    Liu, Haibo
    Xie, Fajun
    Guan, Xin-Yuan
    CANCER RESEARCH, 2012, 72
  • [29] Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma
    Kong, Kar Lok
    Kwong, Dora L.
    Fu, Li
    Chan, Tim Hon Man
    Chen, Leilei
    Liu, Haibo
    Li, Yan
    Zhu, Ying-Hui
    Bi, Jiong
    Qin, Yan-Ru
    Law, Simon Ying Kit
    Guan, Xin-Yuan
    CANCER RESEARCH, 2010, 70 (21) : 8832 - 8841
  • [30] Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma
    Kwon, Junhye
    Park, Misun
    Kim, Ji-Hee
    Lee, Hae Won
    Kang, Moon Chul
    Park, Jong Ho
    TUMOR BIOLOGY, 2015, 36 (10) : 7449 - 7456